ArticleBreast cancer (Tokyo, Japan)2026

Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.

Takeshi Murata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.